- Home
- IVDA vs DWTX Comparison
IVDA vs DWTX Comparison
Compare IVDA & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- DWTX
- Stock Information
- Founded
- IVDA 2003
- DWTX 2012
- Country
- IVDA United States
- DWTX United States
- Employees
- IVDA N/A
- DWTX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- DWTX
- Sector
- IVDA Technology
- DWTX
- Exchange
- IVDA Nasdaq
- DWTX NYSE
- Market Cap
- IVDA 3.7M
- DWTX 4.0M
- IPO Year
- IVDA N/A
- DWTX N/A
- Fundamental
- Price
- IVDA $1.40
- DWTX $3.04
- Analyst Decision
- IVDA
- DWTX
- Analyst Count
- IVDA 0
- DWTX 0
- Target Price
- IVDA N/A
- DWTX N/A
- AVG Volume (30 Days)
- IVDA 213.5K
- DWTX 49.4K
- Earning Date
- IVDA 11-25-2024
- DWTX 11-07-2024
- Dividend Yield
- IVDA N/A
- DWTX N/A
- EPS Growth
- IVDA N/A
- DWTX N/A
- EPS
- IVDA N/A
- DWTX N/A
- Revenue
- IVDA $5,305,154.00
- DWTX N/A
- Revenue This Year
- IVDA $23.76
- DWTX N/A
- Revenue Next Year
- IVDA $229.89
- DWTX N/A
- P/E Ratio
- IVDA N/A
- DWTX N/A
- Revenue Growth
- IVDA N/A
- DWTX N/A
- 52 Week Low
- IVDA $1.27
- DWTX $2.50
- 52 Week High
- IVDA $10.16
- DWTX $23.50
- Technical
- Relative Strength Index (RSI)
- IVDA 43.18
- DWTX N/A
- Support Level
- IVDA $1.27
- DWTX N/A
- Resistance Level
- IVDA $1.56
- DWTX N/A
- Average True Range (ATR)
- IVDA 0.22
- DWTX 0.00
- MACD
- IVDA 0.01
- DWTX 0.00
- Stochastic Oscillator
- IVDA 20.00
- DWTX 0.00
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.